Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -1.22 |
peg ratio | 0.03 |
price to book ratio | 1.06 |
price to sales ratio | 2.78 |
enterprise value multiple | 1.13 |
price fair value | 1.06 |
profitability ratios | |
---|---|
gross profit margin | 18.12% |
operating profit margin | -215.33% |
pretax profit margin | -228.11% |
net profit margin | -227.69% |
return on assets | -27.19% |
return on equity | -68.68% |
return on capital employed | -26.82% |
liquidity ratio | |
---|---|
current ratio | 9.74 |
quick ratio | 8.64 |
cash ratio | 1.30 |
efficiency ratio | |
---|---|
days of inventory outstanding | 169.24 |
operating cycle | 231.18 |
days of payables outstanding | 31.06 |
cash conversion cycle | 200.12 |
receivables turnover | 5.89 |
payables turnover | 11.75 |
inventory turnover | 2.16 |
debt and solvency ratios | |
---|---|
debt ratio | 0.63 |
debt equity ratio | 2.03 |
long term debt to capitalization | 0.66 |
total debt to capitalization | 0.67 |
interest coverage | -26.21 |
cash flow to debt ratio | -0.25 |
cash flow ratios | |
---|---|
free cash flow per share | -0.88 |
cash per share | 1.73 |
operating cash flow per share | -0.85 |
free cash flow operating cash flow ratio | 1.03 |
cash flow coverage ratios | -0.25 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | -35.33 |
Frequently Asked Questions
Pacific Biosciences of California, Inc. (PACB) published its most recent earnings results on 12-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Pacific Biosciences of California, Inc. (NASDAQ:PACB)'s trailing twelve months ROE is -68.68%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Pacific Biosciences of California, Inc. (PACB) currently has a ROA of -27.19%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
PACB reported a profit margin of -227.69% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 9.74 in the most recent quarter. The quick ratio stood at 8.64, with a Debt/Eq ratio of 2.03.